Accepting Cases

Valsartan Side Effects

Valsartan side effects range from headaches and dizziness to hyperkalemia and low blood pressure. Plus, it carries a black box warning for fetal toxicity. Even so, the blood pressure medication generally enjoyed a good reputation for safety until a recall in 2018 revealed batches of drugs containing valsartan were tainted by NDMA, a suspected cancer-causing substance.

Suffering from cancer or liver damage after taking Valsartan?

If you or a loved one suffered from adverse events like liver damage or cancer after Valsartan use, you may be eligible for compensation.

Valsartan
Valsartan Side Effects
  1. Hyperkalemia higher than normal potassium in the blood
  2. Reduced kidney function worsening kidney disease is possible
  3. Liver Damage rare reports of hepatitis
  4. Cancer Risk caused by contamination with NDMA
Fact-Checked

Editors carefully fact-check all Drugwatch content for accuracy and quality.

Drugwatch has a stringent fact-checking process. It starts with our strict sourcing guidelines.

We only gather information from credible sources. This includes peer-reviewed medical journals, reputable media outlets, government reports, court records and interviews with qualified experts.

Related Pages

Valsartan is a high blood pressure drug that is considered generally safe and tolerated better by patients than alternative treatments. Like any drug, however, valsartan comes with side effects.

Some side effects of valsartan are more serious than others and require medical attention. Possible serious side effects of valsartan include allergic reactions and rare instances of liver damage.

Less serious, but more common, valsartan side effects include headache and dizziness. The medication may also cause weight gain, and it poses serious risk to the unborn if taken during pregnancy.

Serious Valsartan Side Effects

Though rare, side effects of valsartan can be serious.

Valsartan carries warnings about the potential for low blood pressure. If you also take water pills and are on a low-salt diet while taking valsartan, you are most likely to develop low blood pressure.

The drug’s label warns health care providers to monitor kidney function and potassium in vulnerable patients. Valsartan has also been linked to rare instances of acute liver injury.

Infographic of Valsartan being linked to acute liver injury
Expand

Valsartan is considered extremely dangerous to the unborn. Patients should not take valsartan medications when they may be pregnant. Valsartan carries a black box warning against use during pregnancy.

Potentially serious side effects of valsartan include:
  • Allergic reactions
  • Impotence
  • Low blood pressure
  • Acute liver injury
  • Low blood pressure
  • Fetal toxicity
  • Reduced renal (kidney) function
  • Hyperkalemia (higher than normal potassium in the blood)

Valsartan Kidney Problems

Patients taking valsartan have reported renal (kidney) impairment to the FDA. For patients with kidney disease, valsartan can make it worse.

Symptoms of kidney impairment include unexplained weight gain and swelling in hands, feet or ankles. Valsartan may increase the level of potassium in your blood. This risk is increased in people with heart failure and kidney problems

Valsartan Allergy

Valsartan may cause serious allergic reactions. If you have trouble breathing, develop hives or if your tongue or throat swells, seek immediate medical help.

In rare cases, the drug has caused angioedema, or severe swelling beneath the skin’s surface. Some patients who took valsartan and experienced angioedema had previously suffered the side effect with other drugs, including ACE inhibitors. The drug’s label advises patients not to take Diovan again if they had angioedema.

Valsartan and Pregnancy Side Effects

Fact
Women who may be pregnant should not take valsartan.

Pregnant women should not take valsartan. Valsartan can cause injury or even death to a developing fetus when taken during the second and third trimesters of pregnancy, according to a black box warning on the drug’s label.

As soon as you know you are pregnant, you should stop taking valsartan as soon as possible.

It’s not known if valsartan passes through breast milk and harms infants. Because of this, you should talk to your doctor before breastfeeding while taking valsartan.

Diovan (Valsartan) and Liver Damage

The FDA has received reports of elevated liver enzymes and very rare reports of hepatitis in patients taking valsartan.

In clinical trials, patients treated with Diovan experienced occasional elevations of liver chemistries, according to the drug label. Three patients treated with valsartan stopped taking the drug because of elevated liver chemistries.

Before starting valsartan, tell your doctor if you have liver problems. The FDA recommends care be exercised in patients with liver disease.

Can Valsartan Cause Erectile Dysfunction? 

The FDA has received reports of impotence among patients taking valsartan. The drug label does not specify whether that impotence refers to erectile dysfunction.

However, some studies have suggested that drugs in the same category of valsartan may actually have a beneficial effect on the sexual function of patients with high blood pressure.

One large study found that valsartan improved all aspects of sexual function, particularly erectile function. The Journal of Clinical Hypertension published the study in January 2007. It involved more than 3,500 patients.

Suffering from liver damage, tumors or cancer after taking Valsartan? Get a Free Case Review

NDMA Contamination Cancer Risk

In July 2018, the FDA announced that batches of valsartan were contaminated by a probable cancer-causing substance called N-nitrosodimethylamine, or NDMA. The agency said the drugs sold in the U.S. have been tainted for as long as four years.

People who are exposed to NDMA may suffer liver damage. NDMA exposure can also increase the risk of tumors in the liver, kidney and lungs.

Lawyers are preparing to file valsartan lawsuits on behalf of people who were diagnosed with liver damage, tumors or cancer after taking recalled valsartan medications.

What Are the Common Side Effects of Valsartan?

Common side effects of valsartan are generally mild and brief. They don’t necessarily require patients to stop taking Diovan or a generic form of valsartan.

The most common side effects of Diovan and other valsartan drugs are:
  • Nausea
  • Cough
  • Dizziness
  • Tiredness
  • Vomiting
  • Diarrhea
  • Headache
  • Pain in the abdomen

Does Diovan (Valsartan) Cause Weight Gain?

Weight gain is not listed on the valsartan label as a side effect. But a study of FDA reports found incidents of weight gain among valsartan patients.

Weight gain was more pronounced for women 60 and older who took the drug for between two and five years, also took the drug Lyrica and had high cholesterol. eHealthMe published the study on its website.

Does Valsartan Cause Hair Loss?

Hair loss is not among the side effects listed on valsartan’s label. A review of FDA reports found that out of more than 20,000 people reporting side effects while taking valsartan, 145 people reported hair loss. It’s not clear whether those people might have experienced hair loss without taking valsartan.

Valsartan Cough

Coughing is a listed side effect of valsartan, but coughing is less common with valsartan than with other blood pressure medications.

Researchers have reported that coughing in valsartan patients was no more common than in patients taking a placebo.

Valsartan HCTZ Side Effects

Valsartan HCTZ is a combination of valsartan and the diuretic hydrochlorothiazide.

In addition to the potential side effects of valsartan, hydrochlorothiazide has its own potential side effects.

Among them are blurred vision, tingling in the hands, legs and feet, and potentially severe skin reactions.

Please seek the advice of a medical professional before making health care decisions.

Related Pages

Did you find Drugwatch helpful?

23 Cited Research Articles

  1. U.S. Environmental Protection Agency. (2014, January). Technical Fact Sheet - N-Nitroso-dimethylamine (NDMA). Retrieved from https://www.epa.gov/sites/production/files/2014-03/documents/ffrrofactsheet_contaminant_ndma_january2014_final.pdf
  2. U.S. National Library of Medicine. (n.d.). Toxnet Toxicology Data Network. N-Nitrosodimethylamine. Retrieved from https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/f?./temp/~MohTXh:1
  3. Emedicinehealth. (n.d.) valsartan (Diovan). Retrieved from https://www.emedicinehealth.com/drug-valsartan/article_em.htm
  4. EverydayHealth. (n.d.). Wat is Diovan (Valsartan)? Retrieved from https://www.everydayhealth.com/drugs/diovan
  5. American College of Cardiology. (n.d.). CardioSmart. Valsartan. Retrieved from https://www.cardiosmart.org/Healthwise/d041/13/d04113
  6. MedicineNet.com. (n.d.) Valsartan. Retrieved from https://www.medicinenet.com/valsartan/article.htm#what_is_valsartan_and_how_does_it_work_mechanism_of_action
  7. Fogan, R. and Zoppi, A. (2011, March). A drug safety evaluation of valsartan. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21142805
  8. National Center for Biotechnology Information. (n.d.) valsartan. Retrieved from https://pubchem.ncbi.nlm.nih.gov/compound/valsartan
  9. U.S. Food and Drug Administration . (2002, August 14). Drug label for Diovan valsartan Capsules. Retrieved from http://s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00177.pdf?1265922797
  10. U.S. National Library of Medicine. (n.d.). Valsartan (By mouth). Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMHT0012598/
  11. U.S. National Library of Medicine. (2011, October 24). Choosing Medicines for High Blood Pressure. Retrieved from https://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0033143/
  12. Husten, L. (2012, September 25). Another One Bites the Dust: Diovan Patent Expires But Generic Valsartan Is MIA. Retrieved from https://www.forbes.com/sites/larryhusten/2012/09/25/another-one-bites-the-dust-diovan-patent-expires-but-generic-valsartan-is-mia/#54889eba2833
  13. Dailymed. (n.d.). Valsartan and Hydrochlorothiazide. Retrieved from https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f1a2d5de-3b7f-40c0-a5bd-fd64fac59d7e&audience=consumer
  14. Sandoz. (2014, July 8). Sandoz launches authorized generic version of Diovan in the US. Retrieved from https://www.sandoz.com/news/media-releases/sandoz-launches-authorized-generic-version-diovanr-us
  15. Elliott W.J., et al. (2001, August 23). Losartan vs valsartan in the treatment of patients with mild to moderate essential hypertension: data from a multicenter, randomized, double-blind, 12-week trial. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11558856
  16. Healthline. (n.d.). Uric Acid Test (Blood Analysis). Retrieved from https://www.healthline.com/health/uric-acid-blood
  17. U.S. Food and Drug Administration. (2018, August 9). FDA updates recalled valsartan-containing product information. Retrieved from https://www.fda.gov/Drugs/DrugSafety/ucm613916.htm?utm_campaign=FDA%20MedWatch%20Recall%20Notice%20-%20Valsartan-Containing%20Product%20by%3A%20Hetero%20Labs&utm_medium=email&utm_source=Eloqua
  18. Fogan, R. and Zoppi, A. (2011, March). A drug safety evaluation of valsartan. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21142805
  19. Medline. (n.d.). Hydrochlorothiazide, Oral Tablet. Retrieved from https://www.healthline.com/health/hydrochlorothiazide-oral-tablet
  20. eHealthMe. (2018, August 13). Valsartan and Weight gain – from FDA reports. Retrieved from https://www.ehealthme.com/ds/valsartan/weight-gain/
  21. Medscape. (2001). Angiotensin II Receptor Antagonists: Well Tolerated and Effective Antihypertensives. Retrieved from https://www.medscape.com/viewarticle/406485_5
  22. Doumas, M. and Douma, S. (2007, January 31) The Effect of Antihypertensive Drugs on Erectile Function: A proposed Management Algorithm. Retrieved from https://onlinelibrary.wiley.com/doi/full/10.1111/j.1524-6175.2005.05285.x
  23. eHealthMe. (2018, August 13). Valsartan and Hair loss – from FDA reports. Retrieved from https://www.ehealthme.com/ds/valsartan/hair-loss/
View All Sources
Who Am I Calling?

Calling this number connects you with Wilson and Peterson, LLP or one of its trusted legal partners. A law firm representative will review your case for free.

Wilson and Peterson, LLP funds Drugwatch because it supports the organization’s mission to keep people safe from dangerous drugs and medical devices.

(877) 239-9641

To contact Drugwatch Managing Editor Kevin Connolly, call (855) 839-9780.